MilliporeSigma
  • Home
  • Search Results
  • Mucin-based stationary phases as tool for the characterization of drug-mucus interaction.

Mucin-based stationary phases as tool for the characterization of drug-mucus interaction.

Journal of chromatography. A (2014-06-05)
Andrea F G Gargano, Michael Lämmerhofer, Hans Lönn, Peter J Schoenmakers, Tomas Leek
ABSTRACT

Mucin glycoproteins belong to a class of high molecular weight, heavy glycosylated, proteins that together with water, salts and lipids constitute mucous secretions. Particular disease states (e.g. obstructive chronic bronchitis and ovarian tumor) are known to modify the composition and the thickness of those barriers. Therefore, it is important to address whether the absorption of potential drug candidates to be administered is influenced by the presence of interaction with this class of proteins. Typically, the methods adopted to characterize drug-protein interaction are dialysis, ultrafiltration and gel filtration. Besides these, bio-affinity chromatographic methods have demonstrated to be valuable tools offering the advantageous characteristics such as simplicity, efficiency, high-throughput capability and robustness. The present contribution reports on the synthesis and analytical characterization of a new chromatographic stationary phase based on covalently immobilized mucin and explores the use of LC-UV affinity zonal chromatography as a tool to screen drugs for their affinity to mucin. A series of different binding chemistries for the covalent linkage of mucin to silica-based supports as well as distinct immobilization protocols (static and dynamic) have been evaluated in order to optimize surface coverage. Resultant stationary phases have been characterized chromatographically by studying the effect of mobile phase and analyte structure on the distribution and retention of test compounds. As conclusive study, we report the evaluation of the retention characteristics of 41 drug-like compounds (having heterogeneous chemical properties) for their interaction with this novel stationary phase.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Silica, nanoparticles, mesoporous, 200 nm particle size, pore size 4 nm
Sigma-Aldrich
LUDOX® CL colloidal silica, 30 wt. % suspension in H2O
Sigma-Aldrich
Silica
Sigma-Aldrich
LUDOX® LS colloidal silica, 30 wt. % suspension in H2O
Sigma-Aldrich
LUDOX® SM colloidal silica, 30 wt. % suspension in H2O
Sigma-Aldrich
LUDOX® HS-30 colloidal silica, 30 wt. % suspension in H2O
Sigma-Aldrich
LUDOX® TM-40 colloidal silica, 40 wt. % suspension in H2O
Sigma-Aldrich
Silica, mesostructured, HMS (wormhole)
Sigma-Aldrich
Silica, nanopowder, spec. surface area 175-225 m2/g (BET), 99.8% trace metals basis
Sigma-Aldrich
Silica, mesostructured, MSU-F (cellular foam)
Sigma-Aldrich
Silicon dioxide, nanopowder (spherical, porous), 5-20 nm particle size (TEM), 99.5% trace metals basis
Sigma-Aldrich
Silicon dioxide, nanopowder, 10-20 nm particle size (BET), 99.5% trace metals basis
Sigma-Aldrich
Silica, mesostructured, MCM-41 type (hexagonal)
Sigma-Aldrich
Silica, mesostructured, MSU-H (large pore 2D hexagonal)
Sigma-Aldrich
LUDOX® AS-40 colloidal silica, 40 wt. % suspension in H2O
Sigma-Aldrich
LUDOX® CL-X colloidal silica, 45 wt. % suspension in H2O
Sigma-Aldrich
LUDOX® AS-30 colloidal silica, 30 wt. % suspension in H2O
Sigma-Aldrich
LUDOX® TMA colloidal silica, 34 wt. % suspension in H2O
Sigma-Aldrich
LUDOX® TM-50 colloidal silica, 50 wt. % suspension in H2O
Sigma-Aldrich
LUDOX® HS-40 colloidal silica, 40 wt. % suspension in H2O
Sigma-Aldrich
LUDOX® AM colloidal silica, 30 wt. % suspension in H2O